Can a smartphone app slow ALS decline?

NCT ID NCT05837507

Terminated Symptom relief Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a digital platform (m-Rehab) could help people with ALS who use non-invasive ventilation. The platform included educational content, remote monitoring, and video consultations. The goal was to see if it could slow the loss of physical function and improve quality of life. The trial was terminated early and enrolled 43 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: multimodal digital platform (m-Rehab) with telemonitoring, education, and teleconsultation
What this could lead to: If it works, this could offer a way to help ALS patients manage their condition at home and potentially slow the loss of function.
What could go wrong: The trial was terminated early with only 43 participants, so results are limited. The platform may not meaningfully change disease progression or quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMYOTROPHIC LATERAL SCLEROSIS

Contacts and locations

Locations

Clinique du Millénaire

Montpellier, 34960, France
Uh Montpellier

Montpellier, Montpellier, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.